...
首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Nuclear morphometry in FNABs of breast disease in Libyans.
【24h】

Nuclear morphometry in FNABs of breast disease in Libyans.

机译:利比亚乳房疾病FNAB中的核形态测量。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Nuclear morphometry can be expected to improve the distinction between benign and malignant lesions. PATIENTS AND METHODS: Forty fine-needle aspiration biopsy (FNAB) samples fixed in 50% ethanol were collected at the African Oncology Institute, Sabratha, Libya, during the period 2004-2007. All diagnoses reported were confirmed histologically. There were 23 cases of infiltrating ductal carcinoma and 17 of benign breast disease. Two different assessment methods were applied: measurements made on cell groups, and those made on free cells. Apocrine metaplasia was excluded. Five different size parameters (include mean nuclear area, MNA) and 6 shape factors were measured. RESULTS: The size parameters showed significant differences between benign and malignant cases. The mean, median and 95% percentiles of nuclear area in both types of assessment were especially significant. The shape parameters were not significant. CONCLUSION: The study suggests that interactive computerized nuclear morphometry is an efficient and successful tool in distinguishing between cases of benign and malignant disease. Combination of our data with earlier free cell data gave the following diagnostic guidelines: Range of overlap in free cell samples: MNA 55 microm2 - 71 micro2. Cut-off values for diagnostic purposes: 100% detection of malignant cases: MNA > 54 microm2 (specificity 84%), 100% detection of benign cases: MNA < 72 microm2 (sensitivity 91%).
机译:背景:核形态测量有望改善良性和恶性病变之间的区别。患者与方法:2004-2007年期间,在利比亚萨布拉塔的非洲肿瘤研究所收集了40个用50%乙醇固定的细针穿刺活检(FNAB)样品。所报告的所有诊断均在组织学上得到证实。浸润性导管癌23例,乳腺良性疾病17例。应用了两种不同的评估方法:对细胞组进行的测量以及对游离细胞进行的测量。顶泌化生被排除在外。测量了五个不同的尺寸参数(包括平均核面积,MNA)和六个形状因子。结果:大小参数显示出良性和恶性病例之间的显着差异。在两种评估类型中,核面积的平均百分比,中位数百分比和95%百分比尤为重要。形状参数不重要。结论:这项研究表明,交互式计算机核形态测定法是一种区分良性和恶性疾病病例的有效且成功的工具。我们的数据与早期游离细胞数据的结合给出了以下诊断准则:游离细胞样品的重叠范围:MNA 55 microm2-71 micro2。用于诊断目的的临界值:100%检测到恶性病例:MNA> 54 microm2(特异性84%),100%检测到良性病例:MNA <72 microm2(敏感性91%)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号